Standout Papers

Effective treatment of severe COVID-19 patients with tocilizumab 2020 2026 2022 20241.8k
  1. Effective treatment of severe COVID-19 patients with tocilizumab (2020)
    Xiaoling Xu, Mingfeng Han et al. Proceedings of the National Academy of Sciences
  2. Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients (2020)
    Yonggang Zhou, Binqing Fu et al. National Science Review
  3. Study of cardiovascular disease prediction model based on random forest in eastern China (2020)
    Yang Li, Haibin Wu et al. Scientific Reports

Immediate Impact

15 from Science/Nature 65 standout
Sub-graph 1 of 21

Citing Papers

Ponsegromab for the Treatment of Cancer Cachexia
2024 Standout
Dictionary of immune responses to cytokines at single-cell resolution
2023 StandoutNature
2 intermediate papers

Works of Xiaoling Xu being referenced

Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
2020 Standout
A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma
2015

Author Peers

Author Last Decade Papers Cites
Xiaoling Xu 537 821 508 2144 1250 80 4.0k
Ying Yao 411 881 783 1927 804 108 4.3k
Jie Yang 362 1430 653 1484 746 158 4.5k
William W. Li 787 1167 816 2457 1434 51 6.3k
Dong Liu 229 512 639 1462 819 71 3.1k
Fan Yang 276 538 926 2915 1720 57 4.5k
Hongxia Liu 816 1355 791 4245 2278 81 7.2k
Xiansheng Liu 785 736 444 1228 672 115 3.2k
Jianhua Mao 543 967 298 1473 808 180 3.9k
Jing Wan 252 448 637 2192 1344 45 3.8k
Congxin Huang 277 1032 761 2476 1526 191 5.9k

All Works

Loading papers...

Rankless by CCL
2026